Sign in
KRBP Stock Price, Chart, Stats & News
Kiromic BioPharma, Inc.
Save
Kiromic BioPharma, Inc. (KRBP) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
KRBP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -162.97% |
ROE | 127.32% |
D/E | -1.16x |
Interest coverage ratio | -7.24x |
KRBP valuation
P/E | – |
P/S | – |
P/B | -0.18x |
P/CF | -0.41x |
P/FCF | -0.04x |
P/OCF | -0.41x |
PEG | -0.01x |
EV multiple | 1.19x |
About
Kiromic BioPharma, Inc. is a biotechnology enterprise that harnesses artificial intelligence to advance allogeneic cell therapies. The company's core mission involves crafting multi-indication T-cell treatments, specifically engineered to combat solid tumors by leveraging the innate capabilities of Gamma Delta T cells. Its developmental pipeline includes ALEXIS-ISO-1, an allogeneic gamma delta CAR-T cell therapy targeting Isomesothelin, and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy designed to address PD-L1.
Similar securities
Based on sector and market capitalization
Report issue